Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 3G-15-2
A Phase 1b/2 Study of MEDI4736 in Combination with Tremelimumab, MEDI4736 Monotherapy, and Tremelimumab Monotherapy in Subjects with Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma
Type:
Treatment
Phase:
Phase I/II
Status:
Not Open (Closed)
Treatments:
Immunotherapy
Randomized:
Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Heinz Josef Lenz, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Anayansi Miloud, D.M., Melissa Wallman, R.N., Rabia Rehman, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.